Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126478) titled 'Study on the Safety and Efficacy of Rocuronium-Sugammadex Combination in Electroconvulsive Therapy' on June 9.
Study Type: Interventional study
Study Design:
Cross-over
Primary Sponsor: Guangdong Second Provincial General Hospital (Guangdong Provincial Emergency Hospital)
Condition:
Depression, depressive state
Intervention:
Experimental group:Succinylcholine ? rocuronium bromide&sugeng sodium ? succinylcholine ? rocuronium bromide&sugeng sodium (succinylcholine 1mg/kg, rocuronium 0.6mg/kg, sugeng sodium 8mg/kg)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-15
Targe...